|
|
Previous Article | Table of Contents
Blood, 15 September 2003, Vol. 102, No. 6, pp. 2312
CORRESPONDENCE
To the editor:
An update on how to treat chronic GVHD
We realized recently that the regimen described for the administration of calcineurin inhibitor for treatment of chronic graft-versus-host disease (GVHD)1 is discrepant from current practice. Previously, we used an alternate-day regimen of calcineurin inhibitor administration,2,3 but we now administer cyclosporine or tacrolimus twice daily for treatment of chronic GVHD. Although results with the 2 regimens have not been formally compared, this change was based primarily on pharmacokinetic considerations.
Mary E. D. Flowers,
Stephanie Lee, and
Georgia Vogelsang
Correspondence: Mary E. D. Flowers, FHCRC, 1100 Fairview Ave. N., Seattle WA 98109
References
- Vogelsang GB. How I treat chronic graft-versus-host disease. Blood. 2001;97: 1196-1201.[Abstract/Free Full Text]
- Sullivan KM, Witherspoon RP, Storb R, et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood. 1988; 72: 555-561.[Abstract/Free Full Text]
- Koc S, Leisenring W, Flowers MED, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood. 2002;100: 48-51.[Abstract/Free Full Text]

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. C. Vigorito, P. V. Campregher, B. E. Storer, P. A. Carpenter, C. K. Moravec, H.-P. Kiem, M. L. Fero, E. H. Warren, S. J. Lee, F. R. Appelbaum, et al.
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD
Blood,
July 16, 2009;
114(3):
702 - 708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Stewart, B. Storer, J. Storek, H. J. Deeg, R. Storb, J. A. Hansen, F. R. Appelbaum, P. A. Carpenter, J. E. Sanders, H.-P. Kiem, et al.
Duration of immunosuppressive treatment for chronic graft-versus-host disease
Blood,
December 1, 2004;
104(12):
3501 - 3506.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|